Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Quinn CP, Sabourin CL, Schiffer JM, Niemuth NA, Semenova VA, Li H, Rudge TL, Brys AM, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Parker SD, Babcock J, Keitel W, Poland GA, Keyserling HL, El Sahly H, Jacobson RM, Marano N, Plikaytis BD, Wright JG.

Clin Vaccine Immunol. 2016 Apr 4;23(4):326-38. doi: 10.1128/CVI.00696-15. Print 2016 Apr.

2.

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.

Pondo T, Rose CE Jr, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker S, Jacobson RM, Poland GA, McNeil MM.

Vaccine. 2014 Jun 12;32(28):3548-54. doi: 10.1016/j.vaccine.2014.04.025. Epub 2014 Apr 24.

3.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.

Vaccine. 2014 Feb 12;32(8):1019-28. doi: 10.1016/j.vaccine.2013.10.039. Epub 2013 Dec 25.

PMID:
24373307
4.
5.

Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial.

Stewart B, Rose CE, Tokars JI, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker SD, Jacobson RM, Poland GA, McNeil MM.

Vaccine. 2012 Aug 31;30(40):5875-9. doi: 10.1016/j.vaccine.2012.06.076. Epub 2012 Jul 17.

6.

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur PL, Turley CB, Rupp RE, Hill H, Wolff M, Noah DL, Ross AC, Cress G, Belshe RB.

J Infect Dis. 2012 Sep 15;206(6):828-37. doi: 10.1093/infdis/jis445. Epub 2012 Jul 16.

7.

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.

Jackson LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, Edupuganti S, Winokur P, Mulligan MJ, Keyserling HL, Kotloff KL, Rouphael N, Noah DL, Hill H, Wolff MC.

J Infect Dis. 2012 Sep 15;206(6):811-20. doi: 10.1093/infdis/jis427. Epub 2012 Jul 10.

8.

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.

Belshe RB, Frey SE, Graham I, Mulligan MJ, Edupuganti S, Jackson LA, Wald A, Poland G, Jacobson R, Keyserling HL, Spearman P, Hill H, Wolff M; National Institute of Allergy and Infectious Diseases-Funded Vaccine and Treatment Evaluation Units.

J Infect Dis. 2011 Mar 1;203(5):666-73. doi: 10.1093/infdis/jiq093. Epub 2011 Jan 31.

9.

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.

Jackson LA, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, Treanor JJ.

BMC Infect Dis. 2010 Mar 17;10:71. doi: 10.1186/1471-2334-10-71.

10.

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.

Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, Quyyumi F, Garg S, Altman JD, Del Rio C, Keyserling HL, Ploss A, Rice CM, Orenstein WA, Mulligan MJ, Ahmed R.

J Immunol. 2009 Dec 15;183(12):7919-30. doi: 10.4049/jimmunol.0803903.

11.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group.

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
12.

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.

Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group.

Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064.

PMID:
18310199
13.

Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.

Shuler CM, Iwamoto M, Bridges CB, Marin M, Neeman R, Gargiullo P, Yoder TA, Keyserling HL, Terebuh PD.

Pediatrics. 2007 Mar;119(3):e587-95.

PMID:
17332179
14.

Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea.

Wang Y, Dennehy PH, Keyserling HL, Tang K, Gentsch JR, Glass RI, Jiang B.

J Virol. 2007 Apr;81(8):3904-12. Epub 2007 Jan 31.

15.

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.

Keyserling HL, Pollard AJ, DeTora LM, Gilmet GP.

Expert Rev Vaccines. 2006 Aug;5(4):445-59. Review.

PMID:
16989625
16.

Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence.

Kapogiannis BG, Satola S, Keyserling HL, Farley MM.

Clin Infect Dis. 2005 Dec 1;41(11):e97-103. Epub 2005 Oct 25.

PMID:
16267724
17.

Vancomycin use in hospitalized pediatric patients.

Keyserling HL, Sinkowitz-Cochran RL, Harris JM 2nd, Levine GL, Siegel JD, Stover BH, Lau SA, Jarvis WR; Pediatric Prevention Network.

Pediatrics. 2003 Aug;112(2):e104-11.

PMID:
12897315
18.

Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response.

Kim MJ, Nafziger AN, Harro CD, Keyserling HL, Ramsey KM, Drusano GL, Bertino JS Jr.

Vaccine. 2003 Mar 7;21(11-12):1174-9.

PMID:
12559795
19.

Progress report--Georgia Immunization Registry.

Keyserling HL.

J Med Assoc Ga. 2002 Summer;91(2):31. No abstract available.

PMID:
12189962
20.

Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples.

Helfand RF, Keyserling HL, Williams I, Murray A, Mei J, Moscatiello C, Icenogle J, Bellini WJ.

J Med Virol. 2001 Dec;65(4):751-7.

PMID:
11745941
22.

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger K, Blatter MM, Quataert SA, Madore DV, Chang I, Malinoski FJ, Hackell JG, Paradiso PR.

Pediatr Infect Dis J. 2001 Feb;20(2):153-9.

PMID:
11224833
23.

The Internet: a practical example of the use of new technology in the assessment of vancomycin use in pediatrics. The Pediatric Prevention Network.

Sinkowitz-Cochran RL, Stein GP, Keyserling HL, Levine GL, Jarvis WR.

Am J Infect Control. 2000 Dec;28(6):459-64. Erratum in: Am J Infect Control 2001 Feb;29(1):64.

PMID:
11114616
24.

Vancomycin use in pediatric hematology-oncology patients.

Hopkins HA, Sinkowitz-Cochran RL, Rudin BA, Keyserling HL, Jarvis WR.

Infect Control Hosp Epidemiol. 2000 Jan;21(1):48-50.

PMID:
10656357
25.

Vancomycin use in pediatric neurosurgery patients.

Shah SS, Sinkowitz-Cochran RL, Keyserling HL, Jarvis WR.

Am J Infect Control. 1999 Dec;27(6):482-7.

PMID:
10586151
26.

Vancomycin use in pediatric cardiothoracic surgery patients.

Shah SS, Sinkowitz-Cochran RL, Keyserling HL, Jarvis WR.

Pediatr Infect Dis J. 1999 Jun;18(6):558-60. No abstract available.

PMID:
10391192
27.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, Madore DV, Chang I, Paradiso PR, Malinoski FJ, Kimura A.

Pediatrics. 1998 Apr;101(4 Pt 1):604-11.

PMID:
9521941
28.

Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination.

Helfand RF, Gary HE Jr, Atkinson WL, Nordin JD, Keyserling HL, Bellini WJ.

Clin Diagn Lab Immunol. 1998 Mar;5(2):135-8.

29.

Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.

Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, Keyserling HL, Carlone GM.

Clin Diagn Lab Immunol. 1997 Jul;4(4):415-22.

30.
31.
32.

Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States.

Bresee JS, Fischer M, Dowell SF, Johnston BD, Biggs VM, Levine RS, Lingappa JR, Keyserling HL, Petersen KM, Bak JR, Gary HE Jr, Sowell AL, Rubens CE, Anderson LJ.

Pediatr Infect Dis J. 1996 Sep;15(9):777-82.

PMID:
8878220
33.

Bacteremia in a pediatric hemodialysis unit secondary to Enterococcus fecalis.

Hymes LC, Warshaw BL, Clowers B, Newsome P, Keyserling HL.

Pediatr Nephrol. 1996 Feb;10(1):55-7.

PMID:
8611357
34.

Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin.

Abzug MJ, Keyserling HL, Lee ML, Levin MJ, Rotbart HA.

Clin Infect Dis. 1995 May;20(5):1201-6.

PMID:
7620000
35.

Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells.

Anderson LJ, Tsou C, Potter C, Keyserling HL, Smith TF, Ananaba G, Bangham CR.

J Infect Dis. 1994 Nov;170(5):1201-8.

PMID:
7963714
36.

Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four, and twelve or fifteen months of age.

Keyserling HL, West DJ, Hesley TM, Bosley C, Wiens BL, Calandra GB.

J Pediatr. 1994 Jul;125(1):67-9.

PMID:
8021788
37.

Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.

Holmes SJ, Fritzell B, Guito KP, Esbenshade JF, Blatter MM, Reisinger KS, Keyserling HL, Rothstein EP, Bernstein HH, Feldman S, et al.

Am J Dis Child. 1993 Aug;147(8):832-6.

PMID:
8352217
38.

Disseminated histoplasmosis caused by Histoplasma capsulatum in an immunocompromised adolescent after exploration of a bat cave.

Gordon SM, Reines SS, Alvarado CS, Nolte F, Keyserling HL, Bryan J.

Pediatr Infect Dis J. 1993 Jan;12(1):102-4. No abstract available.

PMID:
8417414
39.

Mannan antigenemia during invasive candidiasis caused by Candida tropicalis.

McNeill MM, Gerber AR, McLaughlin DW, Vega RA, Winn K, Kaufmann L, Keyserling HL, Jarvis WR.

Pediatr Infect Dis J. 1992 Jun;11(6):493-6. No abstract available.

PMID:
1608689
40.

Immunoglobulin class and subclass-specific monoclonal antibody sandwich ELISA for the detection of antibodies against coxsackieviruses B, types 1-5.

Torfason EG, Pallansch M, Reimer CB, Wickliffe C, Keyserling HL.

J Virol Methods. 1992 Jun;37(3):289-303.

PMID:
1321835
41.

Day-care center attendance and hospitalization for lower respiratory tract illness.

Anderson LJ, Parker RA, Strikas RA, Farrar JA, Gangarosa EJ, Keyserling HL, Sikes RK.

Pediatrics. 1988 Sep;82(3):300-8.

PMID:
3405658
42.

Comparison of five ELISA assays for IgG antibody against coxsackievirus B1.

Torfason EG, Galindo R, Keyserling HL.

J Med Virol. 1988 May;25(1):53-60.

PMID:
2842447
43.

Subclass restriction of human enterovirus antibodies.

Torfason EG, Reimer CB, Keyserling HL.

J Clin Microbiol. 1987 Aug;25(8):1376-9.

44.

Clostridium perfringens meningitis in an infant: case report and literature review.

Long JG, Preblud SR, Keyserling HL.

Pediatr Infect Dis J. 1987 Aug;6(8):752-4. Review. No abstract available.

PMID:
2890135
45.

Catheter-related infection in infants due to an unusual lipophilic yeast--Malassezia furfur.

Long JG, Keyserling HL.

Pediatrics. 1985 Dec;76(6):896-900.

PMID:
3934637
46.

Patient-initiated therapy for recurrent genital herpetic infections.

Nahmias A, Kerrick G, Keyserling HL, Davis G, Alexander J, Corey L, Hatcher V, Luby J, Mills J, Sacks S.

Am J Med. 1982 Jul 20;73(1A):342-6.

PMID:
7048922

Supplemental Content

Loading ...
Support Center